Prognostic and predictive value of epidermal growth factor receptor tyrosine kinase domain mutation status and gene copy number for adjuvant chemotherapy in non-small cell lung cancer. [electronic resource]
Producer: 20110428Description: 139-47 p. digitalISSN:- 1556-1380
- Adenocarcinoma -- drug therapy
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Carcinoma, Squamous Cell -- drug therapy
- Chemotherapy, Adjuvant
- Cisplatin -- administration & dosage
- DNA, Neoplasm -- genetics
- ErbB Receptors -- genetics
- Female
- Gene Dosage
- Humans
- Lung Neoplasms -- drug therapy
- Male
- Mutation -- genetics
- Neoplasm Staging
- Polymerase Chain Reaction
- Prognosis
- Survival Rate
- Vinblastine -- administration & dosage
- Vinorelbine
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.